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Abstract
Background: The Split ends (Spen) family are large proteins characterised by N-terminal RNA
recognition motifs (RRMs) and a conserved SPOC (Spen paralog and ortholog C-terminal) domain.
The aim of this study is to characterize the family at the sequence level.
Results: We describe undetected members of the Spen family in other lineages (Plasmodium and
Plants) and localise SPOC in a new domain context, in a family that is common to all eukaryotes
using profile-based sequence searches and structural prediction methods.
Conclusions: The widely distributed DIO (Death inducer-obliterator) family is related to cancer
and apoptosis and offers new clues about SPOC domain functionality.
Background
The aim of this study was to characterize the Spen family
at the sequence level. The Spen family of proteins partici-
pates in various biological processes. It is involved in neu-
ronal cell fate, survival and axonal guidance [1-3], cell
cycle regulation [4], and repression of head identity in the
embryonic trunk [5]. More recently it has been shown that
the split ends gene participates in Wingless signalling in
the eye, wing and leg imaginal discs [6] in the fly. The
human Spen protein SHARP (SMRT/HDAC1-associated
repressor protein) has been identified as a component of
transcriptional repression complexes in both nuclear
receptor and Notch/RBP-Jkappa signalling pathways [7-
9]. Therefore, the Spen family of proteins appears to regu-
late transcription in several signalling pathways. In addi-
tion, the human Spen protein RBM15 (RNA-binding
motif protein 15) is involved in the recurrent t(1;22)
translocation whose product is the RBM15-MKL1 fusion
protein. This aberrant protein is related to the megakary-
oblastic leukemia 1 (MKL1) [10,11].
On the other hand, DIO and its homologue PHF3 (PHD
finger protein 3) are human proteins that contain a PHD
(Plant Homeodomain) finger and a TFIIS (Transcription
Factor S-II) domain: both domains are usually associated
with transcription [12,13]. The DIO-1 protein regulates
the early stages of cell death in mouse and humans
[14,15]. Experimental evidence shows that the PHF3 pro-
tein is ubiquitously expressed in normal tissues, including
brain. However, its expression is dramatically reduced or
lost in glioblastoma, the most frequent tumour reported
in human brain [12,13]. Although this family has been
shown to be involved in apoptosis and cancer, the under-
lying molecular mechanisms are unclear.
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Sequence profiles of the C-terminal conserved region of
DIO family found the SPOC domain of Spen family at E-
values of 0.083. Reciprocally, the profile of the SPOC
domain of Spen detected the DIO family with an E-value
of 0.05. We localised new members of the Spen and DIO
families in different eukaryote lineages (Figures 1 and 2).
Statistically significant E-values connected all the SPOC
domain-containing families. None of these HMMer pro-
file searches retrieved any new unrelated sequences and,
as stated above, reciprocal searches produced convergent
results.
For the DIO family of sequences, secondary structure pre-
dictions were performed for the SPOC. These predictions
showed good agreement with the crystal structure of the
SPOC domain of SHARP [9] (Figure 1).
To investigate whether fold recognition analysis generated
consistent results, we submitted the SPOC domain of
DIO-1 (swissprot-id: DAT1_HUMAN, residues 1093 to
1199) as a query to an independent fold assignment sys-
tem (see methods). The template 1OW1 (the SPOC
domain of SHARP protein) was found with a Z-score of -
12.2 (estimated error rate <1%) despite its low sequence
homology (16%).
Considering the E-values of the HMMer searches, the reli-
ability of secondary structure predictions, and the fold
assignment results, we are confident that the SPOC
domain is present in the DIO family of proteins.
To highlight the degree of fold-conservation, we generated
a structural model (Fig. 3B) of the SPOC domain of DIO.
In the sequence alignment showed in figure 1, the C-ter-
minal region of SPOC is missing. This region includes:
two small helices (named E and F), which do not form
part of the core and are not well conserved within the
SHARP family, and the β sheet 7, which is part of the β-
barrel core. The high sequence divergence in these region,
made impossible to extend the alignment for automatic
methods. However, for modelling purposes, the align-
ment was carefully extended to the C-terminal region and
a beta sheet was detected in DIO, while the two helices
Representative multiple alignment of the SPOC domainFigure 1
Representative multiple alignment of the SPOC domain. The colouring scheme indicates average BLOSUM62 score 
(correlated to amino acid conservation) in each alignment column: cyan (greater than 3), light red (between 3 and 1.5) and light 
green (between 1.5 and 0.5). The limits of the domains are indicated by the residue positions on each side. The limits of pro-
teins from partially sequenced genes whose full-length proteins are not available are not shown. X-Ray determined structure of 
the SPOC domain [9], pdb-code: 1OW1 is shown below the SHARP sequence (Swissprot-ID:MINT_HUMAN). PHD second-
ary structure prediction [29] for DIO family is shown below the DIO-1 human sequence (Swissprot-Id: DAT1_HUMAN), with 
E indicating a β strand (in red) and H an α helix (in green). The asterisks below the alignment marks the conserved pair 
arginine-tyrosine mentioned in the text. The sequences are named with their swissprot or sptrembl identifications, and also, if 
necessary, with their common species name: Human, Homo sapiens; Frog, Xenopus laevis; Drome, Drosophila melanogaster; 
Caeel, Caenorhabditis elegans; Arath,Arabidopsis thaliana; Ciona, Ciona intestinalis; Yeast, Saccharomyces cerevisiae; Fish, Brachy-
danio rerio; Plafal, Plasmodium falciparum; Aspnidu, Aspergillus nidulans; Pinus, Pinus taeda; Glycine, Glycine max; Schpo, Schizosac-
charomyces pombe; Triti, Triticum aestivum. The "est" prefix identifies consensus sequences manually reconstructed by 
assembling highly similar expressed sequence tags from identical species (conceptual translations). The "unf" prefix identifies 
sequences obtained from Genome BLAST server at NCBI [24]. Complementary information is accessible at: http://
www.pdg.cnb.uam.es/SPOC.Page 2 of 6
(page number not for citation purposes)
BMC Bioinformatics 2004, 5:91 http://www.biomedcentral.com/1471-2105/5/91were missing. Therefore, SPOC domain of DIO adopts a
similar fold than the SPOC domain of SHARP and the
seven strands β-barrel core is maintained (Figure 3).
Discussion
Reported as a protein-protein interaction domain, the
structure of the SPOC domain of SHARP contains a basic
cluster essential for interaction with SMRT (silencing
mediator for retinoid and thyroid receptors) the co-repres-
sor [9]. The Arg 3552 of SHARP is localised in this basic
cluster. Interestingly, this arginine is fully conserved in the
SPOC alignment (Figure 1 and 3). The full conservation of
Arg 3552 may be important, especially when equivalent
substitutions in the protein-protein interaction interface
(e.g. Lysine) might have little effect on the binding capa-
bility of this cluster. Therefore, one explanation for this
fully conserved arginine could be its specific post-transla-
tional modification. Arginine methylation is a common
post-translational modification in transcription regula-
tion proteins that are catalysed by type I and II protein
arginine methyltransferases [16]. Arginine methylation
modulates transcriptional activity and it has recently been
related with a wide range of cellular processes [17].
For instance, proteins like the coactivator of nuclear recep-
tors CBP (CREB-binding protein) follow this schema. In
this protein there is a methylation site at Arg 600. This res-
idue is essential for stabilising the structure of the domain
implicated in CREB recruitment. There is a critical interac-
tion between Arg 600 and Tyr 640 [18]. Disruption of this
interaction by arginine methylation could lead to confor-
mational changes [19]. Analogously, a similar interaction
is observed on the surface of SPOC between the conserved
residues Arg 3552 and Tyr 3602 (Figure 3) [9].
As arginine is one of the aminoacids most frequently
found at the active sites of enzymes [20], alternative func-
tional hypothesis for this conserved arginine is that it
might form part of an active site of unknown function in
the SPOC domain, or contribute to a specific catalytic
Schematic representation of the domain architecture and common features in representative members of the SPOC domain contained familiesFigure 2
Schematic representation of the domain architecture and common features in representative members of the 
SPOC domain contained families. The sequences are named with their swissprot or sptrembl identifications, and also, if 
necessary, with their common species name. The slashes represent inserts that are not shown. The proteins are drawn 
approximately to scale. The localization of the other domains PHD, TFIIS, BRK (BRM and KIS domain) and RRM is according to 
Pfam and SMART families databases [35,36].
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Finger" in Ras-GAP proteins [21].
Conclusions
The SPOC domain is present in different domain architec-
tures among all the eukaryote lineages (Figures 1 and 2).
This study shows that, with the exponential growth of the
sequence databases, sequence analysis sheds new light on
biological function, even when structure is already availa-
ble. The fact that this domain has been identified in cancer
and apoptosis related proteins emphasises its importance
in transcriptional regulation. Additional experimental
Comparison of SPOC domains from SHARP and DIO proteinsFigure 3
Comparison of SPOC domains from SHARP and DIO proteins. (A) Ribbon representation and electrostatic surface 
potential map of structure of the SPOC domain of SHARP protein (PDB code: 1OW1). (B) Ribbon representation and electro-
static surface potential map of homology model of the SPOC domain of DIO protein. Blue indicates positively charged regions, 
whereas red shows negatively charged regions. All the molecules are in the same orientation. Dotted circles indicates the con-
served basic cluster, where is located the conserved arginine-tyrosine pair.Page 4 of 6
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domain-containing families are required to confirm these
hypotheses.
Methods
Sequence analyses
For the sequence analysis we related distant protein fami-
lies via intermediate searches [22] using global hidden
Markov model profiles (using hmmsearch of HMMer
http://hmmer.wustl.edu/) [23]. To improve the profile
quality we followed two approaches: first, BLAST searches
against unfinished genomes [24], and secondly, addi-
tional searches against EST (expressed sequence tags)
databases [25]. This sequence enrichment improved the
quality of the profile that was used to perform the searches
against the non-redundant protein databases. We used
NAIL to view and analyse the HMMer results [26]. The
alignment was produced with HMMer [23] and T-Coffee
software [27] using default parameters and was slightly
refined manually. It is viewed with the Belvu program
[28].
Structural predictions and modeling
Secondary structure predictions were performed using
PHD [29]. Fold recognition analyses were performed
using the FFAS [30] server http://ffas.ljcrf.edu/. The model
was based on the published crystal structure from the
SPOC domain of SHARP protein [9] and obtained using
swiss-model [31]. The model was evaluated using PSQS
[32] and WHATIF [33] tools. Illustrations were generated
with MOLMOL [34].
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